These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12820311

  • 1. Atypical courses of serum tumor markers--4 case reports.
    Klapdor R, Bahlo M, Babinski A.
    Anticancer Res; 2003; 23(2A):845-50. PubMed ID: 12820311
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 5. Investigation of serum tumor markers in the diagnosis of gastric cancer.
    Fan B, Xiong B.
    Hepatogastroenterology; 2011 Mar; 58(105):239-45. PubMed ID: 21510322
    [Abstract] [Full Text] [Related]

  • 6. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
    Fernández-Fernández L, Tejero E, Tieso A, Rabadán L, Munoz M, Santos I.
    Int Surg; 1996 Mar; 81(4):400-2. PubMed ID: 9127805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.
    Chin J Dig Dis; 2006 Mar; 7(3):170-4. PubMed ID: 16808798
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of different tumor markers in the early diagnosis and prognosis of pancreatic carcinoma and chronic pancreatitis.
    Hámori J, Arkosy P, Lenkey A, Sápy P.
    Acta Chir Hung; 1997 Mar; 36(1-4):125-7. PubMed ID: 9408313
    [Abstract] [Full Text] [Related]

  • 13. [Changes in tumor markers CEA, Ca 19-9 and Ca 125 in monitoring of response to chemotherapy in elderly patients with advanced gastric cancer].
    Caponetti R, Caponetti T, Vici P.
    Clin Ter; 2002 Mar; 153(6):373-5. PubMed ID: 12645392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
    Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Casaldi V, Cavaliere F, Carlini M, Garofalo A, Rinaldi G.
    Anticancer Res; 1993 Mar; 13(6B):2409-13. PubMed ID: 8135475
    [Abstract] [Full Text] [Related]

  • 16. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD.
    Hepatogastroenterology; 2004 Mar; 51(59):1544-7. PubMed ID: 15362797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer.
    Okusaka T, Okada S, Sato T, Wakasugi H, Saisho H, Furuse J, Ishikawa O, Matsuno S, Yokoyama S.
    Hepatogastroenterology; 1998 Mar; 45(21):867-72. PubMed ID: 9684148
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D, Roviello F, De Stefano A, Fotia G, Giliberto C, Garosi L, Pinto E.
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.